GetTopicDetailResponse(id=456a966ee9, topicName=IL-36R, introduction=IL-36R, content=null, image=null, comments=1, allHits=1348, url=https://h5.medsci.cn/topic?id=9667, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=66423, tagList=[TagDto(tagId=66423, tagName=IL-36R)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2106352, encodeId=745b210635244, content=<a href='/topic/show?id=16c6334194b' target=_blank style='color:#2F92EE;'>#勃林格殷格翰#</a><a href='/topic/show?id=456a966ee9' target=_blank style='color:#2F92EE;'>#IL-36R#</a>單抗<a href='/topic/show?id=c564105082ba' target=_blank style='color:#2F92EE;'>#佩索利單抗#</a><a href='/topic/show?id=4b3d104922f2' target=_blank style='color:#2F92EE;'>#spesolimab#</a>治療<a href='/topic/show?id=ec6f6488874' target=_blank style='color:#2F92EE;'>#泛發(fā)性膿皰型銀屑病#</a>, objectTitle=勃林格殷格翰IL-36R單抗spesolimab治療銀屑病在中國獲批, objectType=article, longId=752204, objectId=ab9be52204ef, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20221123/b0bdc609c9394292ac843dcac3e87f70.jpg, objectUrl=/article/show_article.do?id=ab9be52204ef, replyNumber=0, likeNumber=139, createdTime=2022-12-16, rootId=0, userName=循證小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ab9be52204ef, moduleTitle=勃林格殷格翰IL-36R單抗spesolimab治療銀屑病在中國獲批, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=ab9be52204ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
